Deregulated cyclin E induces chromosome instability

Nature

Volumn 401, Issue 6750, 1999, Pages 297-300

  Spruck, Charles H ^a   Won, Kwang Ai ^a   Reed, Steven I ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE; CYCLIN E;

ANIMAL CELL; ARTICLE; CELL CYCLE S PHASE; CHROMOSOME INACTIVATION; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE OVEREXPRESSION; GENETIC STABILITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

ANIMALS; BREAST NEOPLASMS; CDC2-CDC28 KINASES; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CYCLIN E; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASES; HUMANS; KARYOTYPING; MUTATION; PROTEIN-SERINE-THREONINE KINASES; RATS; S PHASE; TUMOR CELLS, CULTURED;

ANIMALIA; MAMMALIA;

EID: 0033575920     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/45836     Document Type: Article

References (28)

1. 1-S phase protein kinase. Science 257, 1958-1961 (1992).
2. 1 phase of the cell cycle. Science 257, 1689-1694 (1992).
3. Keyomarsi, K. & Herliczek, T. W. The role of cyclin E in cell proliferation, development and cancer. Prog. Cell Cycle Res. 3, 171-191 (1997).
4. Keyomarsi, K., Conte, D., Toyofuku, W. & Pat Fox, M. Deregulation of cyclin E in breast cancer. Oncogene 11, 941-950 (1995).
5. Dutta, A., Chandra, R., Leiter, L. M. & Lester, S. Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer. Proc. Natl Acad. Sci. USA 92, 5386-5390 (1995).
6. kip1 and cyclin E, alone and in combination, correlate with survival in young breast cancer patients. Nature Med. 3, 222-225 (1997).
7. Nielsen, N. H., Arnerlov, C., Cajander, S. & Landberg, G. Cyclin E expression and proliferation in breast cancer. Anal. Cell Pathol. 17, 177-188 (1998).
8. Dou, Q-P., Pardee, A. B. & Keyomarsi, K. Cyclin E - a better prognostic marker for breast cancer than cyclin D? Nature Med. 2, 254 (1996).
9. Erlanson, M. et al. Expression of cyclin E and the cyclin-dependent kinase inhibitor p27 in malignant lymphomas-prognostic implications. Blood 92, 770-777 (1998).
10. Sakaguchi, T. et al. Prognostic value of cyclin E and p53 expression in gastric carcinoma. Cancer 82, 1238-1248 (1998).
11. Bito, T., Ueda, M., Ito, A. & Ichihashi, M. Less expression of cyclin E in cutaneous squamous cell carcinomas that in benign and premalignant keratinocytic lesions. J. Cutan. Pathol. 24, 305-308 (1997).
12. Bortner, D. M. & Rosenberg, M. P. Induction of mammary gland hyperplasia and carcinomas in transgenic mice expressing human cyclin E. Mol. Cell. Biol. 17, 453-459 (1997).
13. Hua, X. H., Yan, H. & Newport, J. A role for Cdk2 kinase in negatively regulating DNA replication during S phase of the cell cycle. J. Cell Biol. 137, 183-192 (1997).
14. Walter, J., Sun, L. & Newport, J. Regulated chromosomal DNA replication in the absence of a nucleus. Mol. Cell 1, 519-529 (1998).
15. Hinchcliffe, E. H., Li, C., Thompson, E. A., Maller, J. L. & Sluder, G. Requirement of Cdk2-cyclin E activity for repeated centrosome reproduction in Xenopus egg extracts. Science 283, 851-854 (1999).
16. Lacey, K. R., Jackson, P. K. & Stearns, T. Cyclin-dependent kinase control of centrosome duplication. Proc. Natl Acad. Sci. USA 96, 2817-2822 (1999).
17. Gossen, M. & Bujard, H. Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl Acad. Sci. USA 89, 5547-5551 (1992).
18. 1/S phase transition by expression of cyclins D1 and E with an inducible system. Mol. Cell. Biol. 14, 1669-1679 (1994).
19. Won, K-A. & Reed, S. I. Activation of cyclin E/Cdk2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. EMBO J. 15, 4182-4193 (1996).
20. Simpson, G., Roe, A. & Lewontin, R. Quantitative Zoology (Harcourt Brace, Burlingame, New York, 1960).
21. Lengauer, C., Kinzler, K. W. & Vogelstein, B. Genetic instabilities in human cancers. Nature 396, 643-649 (1998).
22. Winey, M. Keeping the centrosome cycle on track. Genome stability. Curr. Biol. 6, 962-964 (1996).
23. Pihan, G. A. et al. Centrosome defects and genetic instability in malignant tumors. Cancer Res. 58, 3974-3985 (1998).
24. Elble, R. & Tye, B. K. Chromosome loss, hyperrecombination, and cell cycle arrest in a yeast mcm1 mutant. Mol. Biol. Cell 9, 971-980 (1992).
25. Mumberg, D. et al. Uncoupling of DNA replication and cell cycle progression by human cyclin E. Oncogene 13, 2493-2497 (1996).
26. Haas, K. et al. Malignant transformation by cyclin E and Ha-Ras correlates with lower sensitivity towards induction of cell death but requires functional Myc and Cdk4. Oncogene 15, 2615-2623 (1997).
27. kip1. Mol. Cell. Biol. 15, 4347-4352 (1995).
28. Xu, X. et al. Centrosome amplifications and a defective G2-M cell cycle checkpoint induce genetic instability in BRCA1 exon 11 isoform-deficient cells. Mol. Cell 3, 389-395 (1999).